SCHEMBL6837491

SCHEMBL6837491

COc1ccccc1NC(=O)c1cc2c(CN[C@@H](C)c3ccccc3)ccc(OC)c2o1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.47
RAB9A P51151 3/20 0.47
NPC1 O15118 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
PDE4A P27815 2/20 0.46
PDE4B Q07343 2/20 0.46
PDE4C Q08493 2/20 0.46
PDE4D Q08499 2/20 0.46
LMNA P02545 1/20 0.46
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
PKM P14618 1/20 0.45
GAA P10253 1/20 0.44
STAT3 P40763 1/20 0.44
STAT1 P42224 1/20 0.44
MAPT P10636 3/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
TSHR P16473 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6839343 0.90 LMNA (0.47) SMN1; SMN2RAB9ANPC1PDE4APDE4B
SCHEMBL6839345 0.90 LMNA (0.47) SMN1; SMN2RAB9ANPC1PDE4APDE4B
SCHEMBL6837619 0.88 LMNA (0.49) THRBSMN1; SMN2LMNAKMT2AMEN1
SCHEMBL6837621 0.88 LMNA (0.49) THRBSMN1; SMN2LMNAKMT2AMEN1
SCHEMBL6837565 0.87 MAPT (0.46) SMN1; SMN2RAB9ANPC1L3MBTL1PDE4A
SCHEMBL6837936 0.87 SMN1; SMN2 (0.49) SMN1; SMN2L3MBTL1LMNAKMT2AMEN1
SCHEMBL6837915 0.86 KMT2A (0.46) SMN1; SMN2RAB9AL3MBTL1PDE4APDE4B
SCHEMBL6837917 0.86 KMT2A (0.46) SMN1; SMN2RAB9AL3MBTL1PDE4APDE4B
SCHEMBL6837649 0.85 ALDH1A1 (0.47) THRBSMN1; SMN2L3MBTL1LMNAKMT2A
SCHEMBL6837813 0.85 NR1H4 (0.43) SMN1; SMN2RAB9APDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716987-B1 PHOSPHODIESTERASE IV INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-04-06 US disclosed
US-6514996-B2 Derivatives of benzofuran or benzodioxole KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-02-04 US disclosed
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE CBR1, CBR3, CYC1 THRB 1933/4885SMN1; SMN2 1477/4885RAB9A 2778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.